ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,02
0,27%
Bitcoin
68 500,24
1,11%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV
  6. ImmunoPrecise Antibodies Ltd (IPA)

  7. ImmunoPrecise Antibodies Ltd (IPA) Actualités

IPA

ImmunoPrecise Antibodies (IPA)

ImmunoPrecise Antibodies Ltd
De:
Trier par:
 Showing the most relevant articles for your search:TSXV:IPA
DateHeureSourceTitreSymboleSociété
09/05/202215h18InvestorsHub NewsWireIPA's Subsidiary BioStrand Secures Second VLAIO Research GrantTSXV:IPAImmunoPrecise Antibodies Ltd
14/04/202214h06InvestorsHub NewsWireIPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue - Adding Artificial Intelligence-Driven Analytics to its Antibody Discovery Capabilities and OfferingsTSXV:IPAImmunoPrecise Antibodies Ltd
29/03/202217h48InvestorsHub NewsWireIPA Announces Agreement to Acquire BioStrand BV - Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial IntelligenceTSXV:IPAImmunoPrecise Antibodies Ltd
14/03/202214h04InvestorsHub NewsWireIPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from Defense Health Agency within US Department of DefenseTSXV:IPAImmunoPrecise Antibodies Ltd
09/03/202214h07InvestorsHub NewsWireIPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03TSXV:IPAImmunoPrecise Antibodies Ltd
08/04/202114h08InvestorsHub NewsWireImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer's DiseaseTSXV:IPAImmunoPrecise Antibodies Ltd
13/02/202107h25PR Newswire (Canada)TSX Venture Exchange Stock Maintenance BulletinsTSXV:IPAImmunoPrecise Antibodies Ltd
23/12/202013h30PR Newswire (Canada)ImmunoPrecise Antibodies to Begin Trading on Nasdaq Stock ExchangeTSXV:IPAImmunoPrecise Antibodies Ltd
21/12/202014h12PR Newswire (Canada)ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter of 2021 Fiscal YearTSXV:IPAImmunoPrecise Antibodies Ltd
14/12/202013h20PR Newswire (Canada)ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine CandidateTSXV:IPAImmunoPrecise Antibodies Ltd
11/12/202013h45PR Newswire (Canada)ImmunoPrecise Collaboration Enables Preclinical Manufacturing of Lead Antibodies Targeting SARS-CoV-2TSXV:IPAImmunoPrecise Antibodies Ltd
25/11/202019h46PR Newswire (Canada)ImmunoPrecise Antibodies Ranked Number 240 Fastest-Growing Company in North America on Deloitte's 2020 Technology Fast 500™TSXV:IPAImmunoPrecise Antibodies Ltd
23/11/202013h00PR Newswire (Canada)IPA Selects Polytope™ Formulations for Pre-Clinical StudiesTSXV:IPAImmunoPrecise Antibodies Ltd
19/11/202013h00PR Newswire (Canada)ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious DiseaseTSXV:IPAImmunoPrecise Antibodies Ltd
18/11/202002h01PR Newswire (Canada)ImmunoPrecise Antibodies Confirms Effective Date of Share ConsolidationTSXV:IPAImmunoPrecise Antibodies Ltd
09/11/202015h11PR Newswire (Canada)ImmunoPrecise Antibodies Files Preliminary Base Shelf Prospectus and Registration StatementTSXV:IPAImmunoPrecise Antibodies Ltd
05/11/202001h08PR Newswire (Canada)ImmunoPrecise Antibodies to Complete Share Consolidation in Preparation for Potential Nasdaq ListingTSXV:IPAImmunoPrecise Antibodies Ltd
03/11/202013h30PR Newswire (Canada)ImmunoPrecise Antibodies and Mila Announce Strategic AI PartnershipTSXV:IPAImmunoPrecise Antibodies Ltd
27/10/202012h28PR Newswire (Canada)ImmunoPrecise and Twist Bioscience Announce Collaboration for the Creation of Novel, Therapeutic ProductsTSXV:IPAImmunoPrecise Antibodies Ltd
08/10/202013h30PR Newswire (Canada)IPA Delivers Lead Candidate Antibodies from B Cell Select™ Platform for at Home SARS-CoV-2 Diagnostic TestTSXV:IPAImmunoPrecise Antibodies Ltd
06/10/202013h30PR Newswire (Canada)IPA's CEO Dr. Jennifer Bath to Appear Live Wednesday on BNN TelevisionTSXV:IPAImmunoPrecise Antibodies Ltd
05/10/202013h30PR Newswire (Canada)ImmunoPrecise Antibodies CEO Dr. Jennifer Bath Appeared Live, Sunday October 4th, on Fox & FriendsTSXV:IPAImmunoPrecise Antibodies Ltd
29/09/202015h10PR Newswire (Canada)ImmunoPrecise Reports Revenue of $3.8 Million and Adjusted EBITDA of $932,000 for the First Quarter of Fiscal 2021TSXV:IPAImmunoPrecise Antibodies Ltd
28/09/202017h59PR Newswire (Canada)IPA CEO Dr. Jennifer Bath to Appear Live Today on Bloomberg TelevisionTSXV:IPAImmunoPrecise Antibodies Ltd
28/09/202013h30PR Newswire (Canada)ImmunoPrecise to Present at the Virtual Gravitas Healthcare Investor DayTSXV:IPAImmunoPrecise Antibodies Ltd
25/09/202013h30PR Newswire (Canada)ImmunoPrecise and LiteVax SARS-CoV-2 Vaccine Begins Pre-Clinical TrialsTSXV:IPAImmunoPrecise Antibodies Ltd
22/09/202013h30PR Newswire (Canada)IPA Europe Significantly Expands its Capabilities, Releasing its Second-Generation B Cell Select ™TSXV:IPAImmunoPrecise Antibodies Ltd
17/09/202013h30PR Newswire (Canada)ImmunoPrecise Announces New Multi-Specific SARS-CoV-2 Antibody Collaboration with ZymeworksTSXV:IPAImmunoPrecise Antibodies Ltd
10/09/202013h30PR Newswire (Canada)ImmunoPrecise Commences Application Process to Dual List on NASDAQTSXV:IPAImmunoPrecise Antibodies Ltd
09/09/202023h37PR Newswire (Canada)ImmunoPrecise Announces Participation at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 202...TSXV:IPAImmunoPrecise Antibodies Ltd
 Showing the most relevant articles for your search:TSXV:IPA

Dernières Valeurs Consultées

BIT
S29769
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés